FBInvestor
Stocks / Aspire Biopharma Hldgs Inc
Institutional Ownership

Aspire Biopharma Hldgs Inc

CUSIP 738920115*W EXP 02/14/203ASBPWQ1 2026

Institutional Holders
29
13F filers
Shares Held
6.69M
Aggregate institutional
Institutional Value
$118.1K
Q1 2026
Net New Holders
+1
1 new · 0 closed

Institutional Ownership Trend

Aggregate 13F value by quarter

Multi-quarter trend — upgrade to see history

Upgrade

Position Activity

Q1 2026

New positions1
Increased1
Decreased4
Sold out0

Institutional Holders

29 funds hold this security · Q1 2026

#FundSharesValueΔ SharesActivity
1Saba Capital Management, L.P.983.6K$17.9K0Held
2Adage Capital Partners Gp, L.L.C.1.05M$17.4K0Held
3Linden Advisors LP900.0K$16.9K0Held
4Aristeia Capital, L.L.C.681.5K$12.4K0Held
5Sculptor Capital LP500.0K$9.1K0Held
6Toronto Dominion Bank516.3K$8.8K100Reduced
7Clear Street Group Inc.330.7K$5.5K100Reduced
8D. E. Shaw & Co., Inc.200.0K$3.3K0Held
9Wolverine Asset Management LLC197.1K$3.3K0Held
10Verition Fund Management LLC191.0K$3.2K241.7KReduced

19 more institutional holders on Premium

See every fund holding Aspire Biopharma Hldgs Inc, with full quarter-over-quarter share changes.

Unlock all holders